Cite
NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids.
MLA
Simoneau, Camille R., et al. “NF-ΚB Inhibitor Alpha Controls SARS-CoV-2 Infection in ACE2-Overexpressing Human Airway Organoids.” Scientific Reports, vol. 14, no. 1, July 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1038/s41598-024-66003-2.
APA
Simoneau, C. R., Chen, P.-Y., Xing, G. K., Hayashi, J. M., Chen, I. P., Khalid, M. M., Meyers, N. L., Taha, T. Y., Leon, K. E., Suryawanshi, R. K., McCavitt-Malvido, M., Ashuach, T., Fontaine, K. A., Rodriguez, L., Joehnk, B., Walcott, K., Vasudevan, S., Fang, X., Maishan, M., & Schultz, S. (2024). NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids. Scientific Reports, 14(1), 1–14. https://doi.org/10.1038/s41598-024-66003-2
Chicago
Simoneau, Camille R., Pei-Yi Chen, Galen K. Xing, Jennifer M. Hayashi, Irene P. Chen, Mir M. Khalid, Nathan L. Meyers, et al. 2024. “NF-ΚB Inhibitor Alpha Controls SARS-CoV-2 Infection in ACE2-Overexpressing Human Airway Organoids.” Scientific Reports 14 (1): 1–14. doi:10.1038/s41598-024-66003-2.